SCHEMBL7786848

SCHEMBL7786848

COc1ccc2[nH]c(-c3ccc(OC)c(C45CC6CC(CC(C6)C4)C5)c3)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
RARA P10276 3/20 0.50
RARB P10826 3/20 0.50
RARG P13631 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
NR1I2 O75469 1/20 0.50
PGR P06401 1/20 0.50
HSPD1 P10809 1/20 0.50
GOT1 P17174 1/20 0.50
GLRA1 P23415 1/20 0.50
BLM P54132 1/20 0.50
HSPE1 P61604 1/20 0.50
HDAC11 Q96DB2 2/20 0.43
HDAC2 Q92769 1/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
NPC1 O15118 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786850 0.92 NPC1 (0.53) LMNAMEN1KMT2ARARARARB
SCHEMBL6535398 0.89 ALOX5 (0.52) LMNAMEN1KMT2ARARARARB
SCHEMBL6571495 0.89 RARA (0.54) LMNAMEN1KMT2ARARARARB
SCHEMBL7795164 0.88 MEN1 (0.45) LMNAMEN1KMT2ARARARARB
SCHEMBL7786877 0.88 RARA (0.49) LMNAMEN1KMT2ARARARARB
SCHEMBL7792893 0.87 PDE4A (0.47) LMNAMEN1KMT2ARARARARB
SCHEMBL7786898 0.87 PDE4A (0.47) LMNAMEN1KMT2ARARARARB
SCHEMBL3807973 0.85 RARB (0.67) LMNAMEN1KMT2ARARARARB
SCHEMBL6535403 0.83 ALOX5 (0.64) LMNAMEN1KMT2ARARARARB
SCHEMBL7786948 0.83 RARB (0.44) LMNAMEN1KMT2ARARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP claimed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US claimed
EP-0643701-A1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-03-22 EP claimed
WO-1992021663-A1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-12-10 WO claimed
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP disclosed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US disclosed